index - Organisation de la cellule musculaire et thérapie de la myopathie centronucléaire autosomique dominante Accéder directement au contenu

Dernières publications

Chiffres clés

78 Publications avec texte intégral

Open Access

55 %

Mots clés

Migration Cell migration Ctdnep1 AAV8 Autophagosome CTL Mechanotransduction Cavins Dystrophin Myopathy Gene therapy Clathrine Cross-presentation Skeletal muscle DNM2 Allele‐specific silencing therapy Atrial heart defects Cell proliferation Nucleus Adeno-Associated virus Cytosquelette Disease heterogeneity Muscular dystrophy Cross-bridge kinetics BAR proteins Biomarkers Dynamine BAF Correlative microscopy Duchenne muscular dystrophy DMD Cavéoles Adeno-associated virus Becker muscular dystrophy BMD Dynamin overexpression Domaine LEM Duchenne Muscular Dystrophy Adult patients ACTN2 Actin nucleus A-type lamins Allele-specific silencing Animal models of human disease Centronuclear myopathy Actin AAV Nesprin Duchenne muscular dystrophy Charcot-Marie-Tooth AD-CNM DMyHC Myosin Antisense oligonucleotides Cellules de crête neurale Skin Atrial cardiac defects Clathrin Dystrophie musculaire de Duchenne Caveolin Allele specific RNA interference Cardiotoxin Neural crest cells Dynamin 2 Core myopathy Developmental myosin heavy chain AFM Adeno-associated virus vector Dullard BMP signaling Dominant centronuclear myopathy Autophagy Developmental biology Cellular neuroscience Dystrophie musculaire d'Emery Dreifuss Alpha-actinin-2 Cancer Coeur Cardiomyopathies Autophagosome maturation RNA interference Nuclear envelope Congenital myopathy Diaphragm Endocytosis Lamin Caveolins CAV-3 gene Cytoskeleton Outflow tract Satellite cell Muscle Caveolae Amphiphysin Dynamin Autosomal dominant centronuclear myopathy Biophysics Myopathie Adhesion Cell signaling Allele-specific silencing therapy Disease modifiers